CPT2 gene mutation analysis and prenatal diagnosis in a family with carnitine palmitoyltransferase II deficiency

TAN Jian-Qiang; CHEN Da-Yu; LI Wu-Gao; LI Zhe-Tao; HUANG Ji-Wei; YAN Ti-Zhen; CAI Ren

doi:10.7499/j.issn.1008-8830.2016.12.017

PDF(1397 KB)

Chinese Journal of Contemporary Pediatrics ›› 2016, Vol. 18 ›› Issue (12) : 1282-1285. DOI: 10.7499/j.issn.1008-8830.2016.12.017

CLINICAL RESEARCH

CPT2 gene mutation analysis and prenatal diagnosis in a family with carnitine palmitoyltransferase II deficiency

TAN Jian-Qiang, CHEN Da-Yu, LI Wu-Gao, LI Zhe-Tao, HUANG Ji-Wei, YAN Ti-Zhen, CAI Ren

Author information +

History +

Abstract

This study aimed to identify the type of carnitine palmitoyltransferase 2 (CPT2) gene mutation in the child with carnitine palmitoyltransferase II (CPT II) deficiency and her parents and to provide the genetic counseling and prenatal diagnosis for the family members. As the proband, a 3-month-old female baby was admitted to the hospital due to fever which had lasted for 8 hours. Tandem mass spectrometric analysis for blood showed an elevated plasma level of acylcarnitine, which suggested CPT II deficiency. The genomic DNA was extracted from peripheral blood of the patient and her parents. Five exon coding regions and some intron regions at the exon/intron boundaries of the CPT2 gene were analyzed by PCR and Sanger sequencing. Amniotic fluid was taken from the mother during the second trimester, and DNA was extracted to analyze the type of CPT2 gene mutation. Sanger sequencing results showed that two mutations were identified in the CPT2 gene of the proband:c.886C > T (p.R296X) and c.1148T > A (p.F383Y), which were inherited from the parents; the second child of the mother inherited the mutation of c.886C > T (p.R296X) and showed normal acylcarnitine spectrum and normal development after birth. It is concluded that the analysis of CPT2 gene mutations in the family suggested that the proband died of CPT II deficiency and that the identification of the mutations was helpful in prenatal diagnosis in the second pregnancy.

Key words

Carnitine palmitoyltransferase Ⅱ deficiency / CPT2 gene / Prenatal diagnosis / Family

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

TAN Jian-Qiang, CHEN Da-Yu, LI Wu-Gao, LI Zhe-Tao, HUANG Ji-Wei, YAN Ti-Zhen, CAI Ren. CPT2 gene mutation analysis and prenatal diagnosis in a family with carnitine palmitoyltransferase II deficiency[J]. Chinese Journal of Contemporary Pediatrics. 2016, 18(12): 1282-1285 https://doi.org/10.7499/j.issn.1008-8830.2016.12.017

References

[1] Isackson PJ, Bennett MJ, Lichter-Konecki U, et al. CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency[J]. Mol Genet Metab, 2008, 94(4): 422-427.
[2] 韩连书, 高晓岚, 叶军, 等. 串联质谱分析干血滤纸片酰基肉碱方法的建立[J]. 中华检验医学杂志, 2005, 28(1): 88-91.
[3] Bonnefont JP, Djouadi F, Prip-Buus C, et al. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects[J]. Mol Aspects Med, 2004, 25(5-6): 495-520.
[4] Yamamoto S, Abe H, Kohgo T, et al. Two novel gene mutations (Glu174→Lys, Phe383→Tyr) causing the "hepatic" form of carnitine palmitoyltransferase II deficiency[J]. Hum Genet, 1996, 98(1): 116-118.
[5] Isackson PJ, Sutton KA, Hostetler KY, et al. Novel mutations in the gene encoding very long-chain acyl-CoA dehydrogenase identified in patients with partial carnitine palmitoyltransferase II deficiency[J]. Muscle Nerve, 2013, 47(2): 224-229.
[6] Wieser T, Deschauer M, Olek K, et al. Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients[J]. Neurology, 2003, 60(8): 1351-1353.
[7] 蔡敏, 姚敏, 木户博, 等. 肉碱棕榈酰基转移酶Ⅱ缺陷症的生化学研究[J]. 交通医学, 2010, 24(6): 592-595.
[8] 董碗娟, 陈万金, 王柠. 肉碱棕榈酰转移酶Ⅱ缺乏症研究进展[J]. 中华神经科杂志, 2009, 42(3): 201-203.
[9] Corti S, Bordoni A, Ronchi D, et al. Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency[J]. J Neurrol Sci, 2008, 266(1-2): 97-103.
[10] 张李霞, 高平明. 肉碱棕榈酰转移酶Ⅱ缺乏症1例[J]. 中国当代儿科杂志, 2009, 11(2): 162.
[11] 戴怡蘅, 张李霞, 邵巧仪. 新生儿期肉碱棕榈酰转移酶Ⅱ缺乏症4例临床分析[J]. 中国实用儿科杂志, 2014, 29(4): 308-310.
[12] DiMauro S, DiMauro PM. Muscle carnitine palmitoyltransferase deficiency and myoglobinuria[J]. Science, 1973, 182(4115): 929-931.
[13] 顾学范. 临床遗传代谢病[M]. 北京: 人民卫生出版社, 2015, 139-141.
[14] Anichini A, Fanin M, Vianey-Saban C, et al. Genotypephenotype correlations in a large series of patients with muscle type CPT II deficiency[J]. Neurol Res, 2011, 33(1): 24-32.
[15] Joshi PR, Young P, Deschauer M, et al. Expanding mutation spectrum in CPT II gene: identification of four novel mutations[J]. J Neurol, 2013, 260(5): 1412-1414.
[16] Joshi PR, Deschauer M, Zierz S. Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients[J]. J Neurol Sci, 2014, 338(1-2): 107-111.
[17] Fanin M, Anichini A, Cassandrini D, et al. Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency[J]. Clin Genet, 2012, 82(3): 232-239.
[18] Thuillier L, Sevin C, Demaugre F, et al. Genotype/phenotype correlation in carnitine palmitoyl transferase II deficiency: lessons from a compound heterozygous patient[J]. Neuromuscul Disord, 2000, 10(3): 200-205.